Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Valone

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|March 1, 1989
Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challengeM Shalit, F H Valone, P C Atkins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Soluble normal and mutated DNA sequences from single-copy genes in human bloodG D Sorenson, D M Pribish, F H Valone, et al.
Methods in Molecular Medicine|February 23, 2011
Bispecific Antibody MDX-210 for Treatment of Advanced Ovarian and Breast CancerP A Kaufman, P K Wallace, F H Valone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
The release of four mediators of immediate hypersensitivity from human leukemic basophilsR A Lewis, E J Goetzl, S I Wasserman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cellsE J Small, P Fratesi, D M Reese, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II studyD R Gandara, F H Valone, E A Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignanciesF H Valone, D R Gandara, J A Luce, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine aloneF H Valone, M Kohler, K Fisher, et al.
Cytotherapy|June 4, 2002
Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancerG G Laport, F H Valone, T M Zimmerman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, F H Valone, J E Herndon, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|March 1, 1989
Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challengeM Shalit, F H Valone, P C Atkins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Soluble normal and mutated DNA sequences from single-copy genes in human bloodG D Sorenson, D M Pribish, F H Valone, et al.
Methods in Molecular Medicine|February 23, 2011
Bispecific Antibody MDX-210 for Treatment of Advanced Ovarian and Breast CancerP A Kaufman, P K Wallace, F H Valone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
The release of four mediators of immediate hypersensitivity from human leukemic basophilsR A Lewis, E J Goetzl, S I Wasserman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cellsE J Small, P Fratesi, D M Reese, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II studyD R Gandara, F H Valone, E A Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignanciesF H Valone, D R Gandara, J A Luce, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine aloneF H Valone, M Kohler, K Fisher, et al.
Cytotherapy|June 4, 2002
Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancerG G Laport, F H Valone, T M Zimmerman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, F H Valone, J E Herndon, et al.
Pageof 6